Arbutus receives $116mm investment from Roivant for HBV pipeline
- Antisense, Oligonucleotides
- Large Molecule
- Nanotechnology, Chips, etc.
- Drug Delivery
- Includes Equity
- R+D and Marketing-Licensing
- Intra-Biotech Deal
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.